Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain.
作者信息
Van Elslande Jan, Vermeersch Pieter, Vandervoort Kris, Wawina-Bokalanga Tony, Vanmechelen Bert, Wollants Elke, Laenen Lies, André Emmanuel, Van Ranst Marc, Lagrou Katrien, Maes Piet
机构信息
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Department of Cardiovascular Sciences, Leuven Belgium.
出版信息
Clin Infect Dis. 2021 Jul 15;73(2):354-356. doi: 10.1093/cid/ciaa1330.
Abstract
摘要
相似文献
1
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain.一株系统发育上不同的毒株导致的有症状的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再次感染
Clin Infect Dis. 2021 Jul 15;73(2):354-356. doi: 10.1093/cid/ciaa1330.
2
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
3
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染：医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
4
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
5
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.密歇根家庭流感疫苗评估（HIVE）队列中冠状病毒的发生：再感染频率和对季节性和严重急性呼吸综合征冠状病毒的血清学反应。
J Infect Dis. 2021 Jul 2;224(1):49-59. doi: 10.1093/infdis/jiab161.
6
Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.再次感染或严重急性呼吸综合征冠状病毒 2 型的激活：系统评价。
Front Public Health. 2021 Jun 11;9:663045. doi: 10.3389/fpubh.2021.663045. eCollection 2021.
7
Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.医护人员预防严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再次感染
Clin Infect Dis. 2021 Oct 5;73(7):1323-1324. doi: 10.1093/cid/ciab069.
8
A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).一例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）早期再次感染病例。
Clin Infect Dis. 2021 Nov 2;73(9):e2827-e2828. doi: 10.1093/cid/ciaa1436.
9
Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.严重急性呼吸综合征冠状病毒 2 型在 2019 冠状病毒病康复的年轻成年人中的再感染：一例报告。
J Med Case Rep. 2021 Jul 16;15(1):382. doi: 10.1186/s13256-021-02965-5.
10
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.南非严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体501Y.V2的严重再感染
Clin Infect Dis. 2021 Nov 16;73(10):1945-1946. doi: 10.1093/cid/ciab129.
引用本文的文献
1
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.《COVID-19组学报告：从个体组学方法到精准医学》
Reports (MDPI). 2023 Sep 22;6(4):45. doi: 10.3390/reports6040045.
2
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.与新型冠状病毒再次感染相关的临床和基因组特征识别
Viruses. 2025 Jun 11;17(6):840. doi: 10.3390/v17060840.
3
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era.奥密克戎时代多重新冠病毒感染的下一代测序
Sci Rep. 2025 Jan 27;15(1):3372. doi: 10.1038/s41598-024-84952-6.
4
Predicting higher risk factors for COVID-19 short-term reinfection in patients with rheumatic diseases: a modeling study based on XGBoost algorithm.预测风湿性疾病患者COVID-19短期再感染的高风险因素：一项基于XGBoost算法的建模研究。
J Transl Med. 2024 Dec 24;22(1):1144. doi: 10.1186/s12967-024-05982-2.
5
Time to death and its predictors among adult patients with COVID-19: A retrospective cohort study in Ethiopia.新冠病毒病成年患者的死亡时间及其预测因素：埃塞俄比亚的一项回顾性队列研究
Front Epidemiol. 2023 Jan 17;2:1065184. doi: 10.3389/fepid.2022.1065184. eCollection 2022.
6
Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data.西西里岛完全接种或接种加强针的mRNA疫苗接种者再次感染SARS-CoV-2的风险较低：一项基于人群的真实世界数据研究
Vaccines (Basel). 2023 Nov 26;11(12):1757. doi: 10.3390/vaccines11121757.
7
COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study.伊朗法尔斯省 COVID-19 再感染率及相关危险因素：一项回顾性队列研究。
Iran J Med Sci. 2023 May;48(3):302-312. doi: 10.30476/IJMS.2022.94615.2598.
8
Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic.新型冠状病毒核衣壳 IgA 和 IgG 抗体的表位覆盖率与新型变异株在 COVID-19 大流行后续波次中再感染的保护作用相关。
Viruses. 2023 Feb 20;15(2):584. doi: 10.3390/v15020584.
9
Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study.评估儿童中可能的 COVID-19 再感染：一项多中心临床研究。
Arch Pediatr. 2023 Apr;30(3):187-191. doi: 10.1016/j.arcped.2023.01.008. Epub 2023 Feb 7.
10
Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2.重新关注受原型SARS-CoV-2挑战的新冠康复者的免疫原性特征。
Vaccines (Basel). 2023 Jan 4;11(1):123. doi: 10.3390/vaccines11010123.
Zotero 插件